Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma

SIMPLE SUMMARY: Immune checkpoint inhibitors, which stimulate the patient’s own T-cells to attack tumor cells, have revolutionized the treatment of metastatic melanoma. However, not all melanoma patients respond to therapy possibly due to a lack of T-cells present in or entering tumor tissue. It is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ammann, Nadine L., Schwietzer, Yasmin F., Mess, Christian, Stadler, Julia-Christina, Geidel, Glenn, Kött, Julian, Pantel, Klaus, Schneider, Stefan W., Utikal, Jochen, Bauer, Alexander T., Gebhardt, Christoffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688620/
https://www.ncbi.nlm.nih.gov/pubmed/36428768
http://dx.doi.org/10.3390/cancers14225676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688620/
https://www.ncbi.nlm.nih.gov/pubmed/36428768
http://dx.doi.org/10.3390/cancers14225676

Ejemplares similares